Ovarian granulocytic sarcoma with central nervous system involvement

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
• Granulocytic sarcoma (GS) and central nervous system (CNS) involvement are known AML complications.
• Previous studies suggest isolated GS or CNS involvement may not significantly impact AML prognosis.

Observation:

• Two cases of AML presenting with both ovarian GS and CNS involvement are described.
• Both patients experienced rapid disease progression and an unfavorable clinical course.
• The concurrent presence of ovarian GS and CNS involvement was noted.

Findings:

• The combination of ovarian granulocytic sarcoma and central nervous system involvement in AML may indicate a poor prognostic significance.
• This association appears to worsen the overall prognosis of acute myeloid leukemia.
• The study challenges the notion that isolated GS or CNS involvement is not prognostically significant.

Implications:

• Clinicians should consider the combined impact of GS and CNS involvement when assessing AML prognosis.
• Further research is warranted to validate the prognostic value of this dual complication in AML.
• This finding may influence treatment strategies for AML patients with specific extramedullary disease patterns.